Market leading innovator in laboratory digital transformation, Scitara, has announced a collaboration with scientific analytical technology leader, Revvity Signals. The move will support the integration of the Revvity Signals One™ informatics platform, which provides seamless, end-to-end scientific data and workflow management, with laboratory instruments...
Read on more about the collaboration between Revvity Signals and TetraScience. See how this partnership can facilitate faster and better scientific decision-making.
Discover how Signals Research™ Suite platform by Revvity Signals Software helps integrate scientific data silos and streamline research workflows. Learn more today.
Learn how Revvity Signals is further expanding its industry-leading Signals™ Informatics capabilities with innovative solutions for scientific research and discovery.
Roundtable entitled Informatics strategies for driving Biologics discovery moderated by Dannys Martinez, Field Application Scientist at Revvity Signals.
Join us for the Medicinal Chemistry Strategy Meeting Europe 2022 by Revvity Signals. Connect with experts and learn about the latest trends in drug discovery.
The Indian pharma sector is poised to take the lead in the biosimilars race and continue to live up to its reputation as the pharmacy of the world. However, the race is extremely competitive and fraught with challenges. Biosimilar development and manufacturing processes have different challenges than the established process for small molecules because of...
The Cellular Thermal Shift Assay’s (CETSA) unique approach allows the assessment and quantification of target engagement under physiological conditions without modifying the compound or protein. In this webinar we will share best practices to analyze CETSA data starting from reader files to curve fits in one repeatable workflow, and more.
